Eduardo Davila

6PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2026
Decitabine reverses innate immune gene suppression in rare melanomas.

|Mar 11, 2026
Engineering T Cells with a Tumor-Reactive Chimeric T-cell Receptor Reduces Exhaustion and Promotes Persistence to Elicit Enhanced Antitumor Responses.

Joey C Magno, Jitao Guo, Spencer C Hall

|May 16, 2025
A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.

Breelyn A Wilky, Katherine A Julian, Alessandra Maleddu

|Dec 27, 2023
Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial.

Bradley Haverkos, Jasmine Zain, Manali Kamdar

|Jan 07, 2021
MyD88 Costimulation in Donor CD8+ T Cells Enhances the Graft-versus-Tumor Effect in Murine Hematopoietic Cell Transplantation.

Nicholas G Ciavattone, Long Wu, Rachel O'Neill

|Jun 14, 2020
Induction of IRAK-M in melanoma induces caspase-3 dependent apoptosis by reducing TRAF6 and calpastatin levels.

Degui Geng, Nicholas Ciavattone, Jackline Joy Lasola

Pageof 1

Frequent Collaborators

2 joint publications

Breelyn A Wilky

1 joint publications

Jackline Joy Lasola

1 joint publications

Rojesh Shrestha

1 joint publications

Alexandra Vlk